Literature DB >> 26272755

TRPM4 in cardiac electrical activity.

Romain Guinamard1, Patrice Bouvagnet2, Thomas Hof3, Hui Liu4, Christophe Simard3, Laurent Sallé3.   

Abstract

TRPM4 forms a non-selective cation channel activated by internal Ca(2+). Its functional expression was demonstrated in cardiomyocytes of several mammalian species including humans, but the channel is also present in many other tissues. The recent characterization of the TRPM4 inhibitor 9-phenanthrol, and the availability of transgenic mice have helped to clarify the role of TRPM4 in cardiac electrical activity, including diastolic depolarization from the sino-atrial node cells in mouse, rat, and rabbit, as well as action potential duration in mouse cardiomyocytes. In rat and mouse, pharmacological inhibition of TRPM4 prevents cardiac ischaemia-reperfusion injuries and decreases the occurrence of arrhythmias. Several studies have identified TRPM4 mutations in patients with inherited cardiac diseases including conduction blocks and Brugada syndrome. This review identifies TRPM4 as a significant actor in cardiac electrophysiology. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Arrhythmias; Brugada; Calcium-activated non-selective cation channel; Cardioprotection; TRPM4

Mesh:

Substances:

Year:  2015        PMID: 26272755     DOI: 10.1093/cvr/cvv213

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  22 in total

Review 1.  Purkinje physiology and pathophysiology.

Authors:  Penelope A Boyden
Journal:  J Interv Card Electrophysiol       Date:  2018-07-28       Impact factor: 1.900

2.  Excitation of murine cardiac myocytes by nanosecond pulsed electric field.

Authors:  Jan E Azarov; Iurii Semenov; Maura Casciola; Andrei G Pakhomov
Journal:  J Cardiovasc Electrophysiol       Date:  2019-01-17

Review 3.  Investigational antiarrhythmic agents: promising drugs in early clinical development.

Authors:  Jordi Heijman; Shokoufeh Ghezelbash; Dobromir Dobrev
Journal:  Expert Opin Investig Drugs       Date:  2017-07-20       Impact factor: 6.206

4.  Involvement of TRPM4 in detrusor overactivity following spinal cord transection in mice.

Authors:  F Aura Kullmann; Jonathan M Beckel; Bronagh McDonnell; Christian Gauthier; Andrew M Lynn; Amanda Wolf-Johnston; Anthony Kanai; Irina V Zabbarova; Youko Ikeda; William C de Groat; Lori A Birder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-27       Impact factor: 3.000

5.  TRPM4 non-selective cation channel in human atrial fibroblast growth.

Authors:  Christophe Simard; Christophe Magaud; Racim Adjlane; Quentin Dupas; Laurent Sallé; Alain Manrique; Patrick Bois; Jean-François Faivre; Romain Guinamard
Journal:  Pflugers Arch       Date:  2020-10-13       Impact factor: 3.657

6.  TRPM4 non-selective cation channels influence action potentials in rabbit Purkinje fibres.

Authors:  Thomas Hof; Laurent Sallé; Laurent Coulbault; Romain Richer; Joachim Alexandre; René Rouet; Alain Manrique; Romain Guinamard
Journal:  J Physiol       Date:  2015-12-14       Impact factor: 5.182

7.  Propagation Failure by TRPM4 Overexpression.

Authors:  Namit Gaur; Thomas Hof; Michel Haissaguerre; Edward J Vigmond
Journal:  Biophys J       Date:  2018-12-07       Impact factor: 4.033

8.  Upregulation of transient receptor potential melastatin 4 (TRPM4) in ventricular fibroblasts from heart failure patients.

Authors:  Jianlin Feng; Pengyu Zong; Jiajie Yan; Zhichao Yue; Xin Li; Chevaughn Smith; Xun Ai; Lixia Yue
Journal:  Pflugers Arch       Date:  2021-02-16       Impact factor: 3.657

Review 9.  Ion Channel Disorders and Sudden Cardiac Death.

Authors:  Anna Garcia-Elias; Begoña Benito
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

Review 10.  Transient receptor potential channels in cardiac health and disease.

Authors:  Thomas Hof; Sébastien Chaigne; Alice Récalde; Laurent Sallé; Fabien Brette; Romain Guinamard
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.